TIPRL是一种潜在的双边分子,可以针对癌症进行向和重新向
Jie Gao1, Tiantian You1, Jiao Liu1
1Department of Pharmacy, Zibo Central Hospital, Zibo, 255036, China.
Cell biochemistry and biophysics
|June 18, 2024
概括
拉巴胺素 (mTOR) 途径的机械性标及其调节剂TIPRL对癌细胞生长和存活至关重要. 了解它们在亡和扩散中的作用是开发新癌症疗法的关键.
科学领域:
- 细胞生物学 细胞生物学
- 生物化学 生物化学
- 在瘤学瘤学.
背景情况:
- 拉巴胺素 (TOR) 蛋白的点在物种中保持一致,属于与PIK相关的激酶家族.
- 氨酸/氨酸蛋白酸酶 (PP2A,PP4,PP6) 参与哺乳动物细胞中的TOR信号传递.
- 类似TOR信号通路调节器 (TIPRL) 蛋白调节PP2A活动,并参与各种细胞过程.
研究的目的:
- 审查TOR途径在癌细胞亡和扩散中的重要性.
- 专注于TOR信号和TIPRL在癌症发展中的特定作用.
- 探索TIPRL在NSCLC和HCC等癌症中的临床相关性.
主要方法:
- 对TOR信号,TIPRL和癌症现有研究的文献综述.
- 在细胞过程中分析TOR和TIPRL的调节机制.
- 检查各种癌症类型中报告的TIPRL表达水平.
主要成果:
- 在非小细胞肺癌 (NSCLC) 和肝细胞癌 (HCC) 中观察到TIPRL的水平增加.
- 提议的TIPRL功能包括调节mTOR信号,抑制细胞灭绝和生物发生,并促进PP2A回收利用.
- 在控制癌细胞的增殖和存活方面,TOR通路起着重要的作用.
结论:
- TOR途径和TIPRL是癌细胞亡和扩散的关键调节者.
- 在某些癌症中提升的TIPRL水平表明其作为生物标志物或治疗点的潜力.
- 对于癌症治疗策略,对TOR信号和TIPRL的进一步研究是有必要的.
相关概念视频
02:57Targeted Cancer Therapies
7.5K
The targeted cancer therapies, also known as “molecular targeted therapies,” take advantage of the molecular and genetic differences between the cancer cells and the normal cells. It needs a thorough understanding of the cancer cells to develop drugs that can target specific molecular aspects that drive the growth, progression, and spread of cancer cells without affecting the growth and survival of other normal cells in the body.
There are several types of targeted therapies against...
There are several types of targeted therapies against...
7.5K
02:50Combination Therapies and Personalized Medicine
4.9K
Combining two or more treatment methods increases the life span of cancer patients while reducing damage to vital organs or tissue from the overuse of a single treatment. Combination therapy also targets different cancer-inducing pathways, thus reducing the chances of developing resistance to treatment.
The combination of the drug acetazolamide and sulforaphane is a good example of combination therapy to treat cancer. The cells in the interior of a large tumor often die due to the hypoxic and...
The combination of the drug acetazolamide and sulforaphane is a good example of combination therapy to treat cancer. The cells in the interior of a large tumor often die due to the hypoxic and...
4.9K
01:27Transducer Mechanism: Enzyme-Linked Receptors
2.4K
Enzyme-linked receptors are cell-surface receptors acting as an enzyme or associating with an enzyme intracellularly. They make excellent drug targets. Drugs can bind to the extracellular ligand-binding domain or directly affect their enzymatic domain and alter their activity.
Major types that are helpful drug targets include:
Major types that are helpful drug targets include:
2.4K
01:27Tumor Immunotherapy
511
Immunotherapy is a treatment that boosts or manipulates the immune system to fight diseases, including cancer. For instance, by stimulating an immune response through vaccinations against viruses that cause cancers, like hepatitis B virus and human papillomavirus, these diseases can be prevented. Nonetheless, some cancer cells can avoid the immune system due to their rapid mutation and division. The immune response to many cancers involves three phases: elimination, equilibrium, and escape.
511
02:39lncRNA - Long Non-coding RNAs
8.6K
In humans, more than 80% of the genome gets transcribed. However, only around 2% of the genome codes for proteins. The remaining part produces non-coding RNAs which includes ribosomal RNAs, transfer RNAs, telomerase RNAs, and regulatory RNAs, among other types. A large number of regulatory non-coding RNAs have been classified into two groups depending upon their length – small non-coding RNAs, such as microRNA, which are less than 200 nucleotides in length, and long non-coding RNA...
8.6K